Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/150652
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat |
Autor: | Abalo, Raquel CSIC ORCID; Uranga-Ocio, José Antonio; Girón, Rocío CSIC ORCID; Vera, Gema; López-Pérez, Ana E.; Martín, M. Isabel CSIC | Palabras clave: | 5-fluorouracil Diarrhea Gastrointestinal motility Chemotherapy-induced adverse effects Cannabinoids |
Fecha de publicación: | 2017 | Editor: | John Wiley & Sons | Citación: | Neurogastroenterology and Motility 29(3): e12952 (2017) | Resumen: | [Background]: The antineoplastic drug 5-fluoruracil (5-FU) is a pirimidine analog, which frequently induces potentially fatal diarrhea and mucositis. Cannabinoids reduce gastrointestinal motility and secretion and might prevent 5-FU-induced gut adverse effects. Here, we asked whether cannabinoids may prevent diarrhea and mucositis induced by 5-FU in the rat. [Methods]: Male Wistar rats received vehicle or the non-selective cannabinoid agonist WIN 55,212-2 (WIN; 0.5 mg kg injection, 1 injection day, 4 consecutive days) by intraperitoneal (ip) route; on the first 2 days, animals received also saline or 5-FU (150 mg kg injection, cumulative dose of 300 mg kg). Gastrointestinal motor function was radiographically studied after barium contrast intragastric administration on experimental days 1 and 4. Structural alterations of the stomach, small intestine and colon were histologically studied on day 4. PAS staining and immunohistochemistry for Ki67, chromogranin A and CD163 were used to detect secretory, proliferating, and endocrine cells, and activated macrophages respectively. [Key Results]: As shown radiographically, 5-FU induced significant gastric emptying delay (on days 1 and 4) and diarrhea (on day 4). WIN did not significantly alter the motility curves obtained for either control or 5-FU-treated animals but tended to reduce the severity of 5-FU-induced diarrhea and increased permanence of barium from day 1 to the beginning of day 4 in 5-FU-treated animals. 5-FU-induced mucositis was severe and not counteracted by WIN. [Conclusions and Inferences]: 5-FU-induced diarrhea, but not mucositis, was partly prevented by WIN at a low dose. Cannabinoids might be useful to prevent chemotherapy-induced diarrhea. | URI: | http://hdl.handle.net/10261/150652 | DOI: | 10.1111/nmo.12952 | Identificadores: | doi: 10.1111/nmo.12952 e-issn: 1365-2982 issn: 1350-1925 |
Aparece en las colecciones: | (CIAL) Artículos (IQM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
26
checked on 18-abr-2024
WEB OF SCIENCETM
Citations
23
checked on 21-feb-2024
Page view(s)
355
checked on 24-abr-2024
Download(s)
147
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.